The aggregated form of an AAMP derived peptide behaves as a heparin sensitive cell binding agent

Biotechnology and Bioengineering

Volumn 54, Issue 4, 1997, Pages 365-372

  Beckner, Marie E ^a,c   Krutzsch, Henry C ^a   Tsokos, Maria ^a   Moul, Douglas E ^b   Liotta, Lance A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

AAMP peptide; biocompatible material; cell adhesion; cell immobilization; heparin binding; peptide mapping

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; PROTEINS;

ANGIO-ASSOCIATED MIGRATORY CELL PROTEIN; CELL ADHESION; HEPARIN; TUMOR CELLS;

CELL IMMOBILIZATION;

CELL PROTEIN; HEPARIN;

AMINO ACID SEQUENCE; ARTICLE; BIOCOMPATIBILITY; BIOTECHNOLOGY; CELL ADHESION; PROTEIN PROTEIN INTERACTION;

EID: 0342547163     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19970520)54:4<365::AID-BIT10>3.0.CO;2-F     Document Type: Article

References (17)

1. Bakker, F. C., Wille, F., Patka, P., Haarman, H. J. T. M. 1995. Surgical treatment of liver injury with an absorbable mesh: an experimental study. J. Trauma 38: 891-894.
2. Beckner, M. E., Krutzsch, H. C., Stracke, M. L., Williams, S. T., Gallardo, J. A., Liotta, L. A. 1995. Identification of a new immunoglobulin superfamily protein expressed in blood vessels with a heparin-binding consensus sequence. Cancer Res. 55: 2140-2149.
3. Beckner, M. E., Stracke, M. L., Liotta, L. A., Schiffmann, E. 1990. Glycolysis as primary energy source in tumor cell chemotaxis. J. Natl. Cancer Inst. 82: 1836-1840.
4. Dai, W., Saltzman, W. M. 1996. Fibroblast aggregation by suspension with conjugates of poly(ethylene glycol) and RGD. Biotechnol. Bioeng. 50: 349-356.
5. Freed, L. E., Vunjak-Novakovic, G. V., Drinker, P. A., Langer, R. 1993. Bioreactor based on suspended particles of immobilized enzyme. Ann. Biomed. Eng. 21: 57-65.
6. Gorman, J. H., Edmunds, L. H. 1995. Blood anesthesia for cardiopulmonary bypass. J. Card. Surg. 10: 270-279.
7. Hatori, N., Yoshizu, H., Haga, Y., Kusama, Y., Takeshima, S., Segawa, D., Tanaka, S. 1994. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass. Artif. Org. 18: 904-910.
8. Iozzo, R. V. 1988. Cell surface heparan sulfate proteoglycan and the neoplastic phenotype. J. Cell. Biochem. 37: 61-78.
9. Jen, A. C., Wake, M. C., Mikos, A. G. 1996. Review: Hydrogels for cell immobilization. Biotechnol. Bioeng. 50: 357-364.
10. Massia, S. P., Hubbell, J. A. 1992. Immobilized amines and basic amino acids as mimetic heparin-binding domains for cell surface proteoglycan-mediated adhesion. J. Biol. Chem. 267: 10133-10141.
11. Nagaoka, S., Kawakami, H. 1995. Inhibition of bacterial adhesion and biofilm formation by a heparinized hydrophilic polymer. ASAIO J. 41: M365-M368.
12. Nojiri, C., Hagiwara, K., Yokoyama, K., Kuribayashi, E., Hidaka, K., Ishida, N., Horiuchi, K., Oshiyama, H., Nogawa, A., Kido, T., Kijima, T., Akutsu, T. 1995. Evaluation of a new heparin bonding process in prolonged extracorporeal membrane oxygenation. ASAIO J. 41: M561-M567.
13. Peppas, N. A., Langer, R. 1994. New challenges in biomaterials. Science 263: 1715-1720.
14. Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660-672.
15. Steinberg, B. M., Grossi, E. A., Schwartz, D. S., McLoughlin, D. E., Aguinaga, M., Bizekis, C., Greenwald, J., Flisser, A., Spencer, F. C., Galloway, A. C., Colvin, S. B. 1995. Heparin binding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann. Thorac. Surg. 60: 525-529.
16. Stracke, M. L., Engel, J. D., Wilson, L. W., Rechter, M. M., Liotta, L. A., Schiffmann, E. 1989. The type 1 insulin-like growth factor receptor is a motility receptor in human melanoma cells. J. Biol. Chem. 264: 21544-21549.
17. Stracke, M. L., Guirguis, R., Liotta, L. A., Schiffmann, E. 1987. Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. Biochem. Biophys. Res. Commun. 146: 339-345.